Addex Therapeutics Ltd. financial data

Symbol
ADXN on Nasdaq
Location
Geneva, Switzerland
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 15 May 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128,292,969 shares 2.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets CHF10,678,303 CHF 130%